BackOnconova Therapeutics Overview

Onconova Therapeutics Total Liabilities

Latest total liabilities for ONTX: $13M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$13.47M

Peer trimmed avg / median

Loading

Onconova Therapeutics Total Liabilities History

Loading

Onconova Therapeutics vs. peers: Total Liabilities Comparison

Loading

Onconova Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Onconova Therapeutics (ONTX) FAQ

The latest total liabilities for ONTX is $13M as of March 2026. Investors often review this figure alongside Onconova Therapeutics's historical trend and sector peers before judging valuation or financial health.

A total liabilities figure of $13M for ONTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ONTX's total liabilities ($13M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Onconova Therapeutics's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.